Keywords: USA, Biomedical reserch, Funding, Drug Approvals

“Era of rapid growth in biomedical research over,” warn US scientists

Article | 13 January 2010

After a decade of remarkable growth, total annual funding for biomedical research in the USA has decelerated and may have even fallen when adjusted for inflation. That is the conclusion of a study today published in the Journal of the American Medical Association.

"The era of rapid expansion in biomedical research funding that began in the 1990s has ended," said Ray Dorsey, a neurologist at the University of Rochester Medical Center, USA, and lead author of the study. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in